摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-carbamimidoyl-4-phenylpiperazine-1-carboximidic acid amide | 786578-60-7

中文名称
——
中文别名
——
英文名称
N-carbamimidoyl-4-phenylpiperazine-1-carboximidic acid amide
英文别名
N-carbamimidoyl-4-phenyl-piperazine-1-carboximidic acid amide;1-(4-Phenyl-piperazinyl-(1)-formimidoyl)-guanidin;1-(4-Phenyl)piperazinyldiguanid;N-[amino(imino)methyl]-4-phenylpiperazine-1-carboximidamide;N-(diaminomethylidene)-4-phenylpiperazine-1-carboximidamide
N-carbamimidoyl-4-phenylpiperazine-1-carboximidic acid amide化学式
CAS
786578-60-7
化学式
C12H18N6
mdl
MFCD15203589
分子量
246.315
InChiKey
LQWASOLNMNSTSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    158-160 °C
  • 沸点:
    390.0±52.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    94.7
  • 氢给体数:
    3
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-carbamimidoyl-4-phenylpiperazine-1-carboximidic acid amide氰基磷酸二乙酯三乙胺 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 26.5h, 生成 methyl {4-[{[2-amino-4-(4-phenylpiperazin-1-yl)-1,3,5-triazin-6-yl]methyl}amino]benzoyl}methioninate
    参考文献:
    名称:
    Saczewski; Bulakowska, Polish Journal of Chemistry, 2005, vol. 79, # 4, p. 739 - 748
    摘要:
    DOI:
  • 作为产物:
    描述:
    N-苯基哌嗪二聚氰胺盐酸 作用下, 以 为溶剂, 反应 3.0h, 生成 N-carbamimidoyl-4-phenylpiperazine-1-carboximidic acid amide
    参考文献:
    名称:
    Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents
    摘要:
    The discovery of a novel class of HCV inhibitors is described. The new amidinourea compounds were designed as isosteric analogues of the antiviral drug moroxydine. The two derivatives 11g and 11h showed excellent HCV inhibition activity and viability and proved to inhibit a step(s) of the RNA replication. The new compounds have been synthesized in only three synthetic steps from cheap building blocks and in high yields, thus turning to be promising drug candidates in the development of cheaper HCV treatments. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.09.029
点击查看最新优质反应信息

文献信息

  • Pomarnacka, Elzbieta; Bednarski, Patrick; Grunert, Renate, Acta poloniae pharmaceutica, 2004, vol. 61, # 6, p. 461 - 466
    作者:Pomarnacka, Elzbieta、Bednarski, Patrick、Grunert, Renate、Reszka, Przemyslaw
    DOI:——
    日期:——
  • Saczewski; Bulakowska, Polish Journal of Chemistry, 2005, vol. 79, # 4, p. 739 - 748
    作者:Saczewski、Bulakowska
    DOI:——
    日期:——
  • Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents
    作者:Andrea Magri、Roisin Reilly、Nicolò Scalacci、Marco Radi、Michael Hunter、Manon Ripoll、Arvind H. Patel、Daniele Castagnolo
    DOI:10.1016/j.bmcl.2015.09.029
    日期:2015.11
    The discovery of a novel class of HCV inhibitors is described. The new amidinourea compounds were designed as isosteric analogues of the antiviral drug moroxydine. The two derivatives 11g and 11h showed excellent HCV inhibition activity and viability and proved to inhibit a step(s) of the RNA replication. The new compounds have been synthesized in only three synthetic steps from cheap building blocks and in high yields, thus turning to be promising drug candidates in the development of cheaper HCV treatments. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多